Potential of Hydroxysafflor yellow A, the main compound of Kasumba Turate (Carthamus tinctorius ) as Anti-Inflammatory in Lung, Liver and Cardiac Tissues: A Literature Review
DOI:
https://doi.org/10.23917/pharmacon.v21i2.4908Keywords:
Inflammation, Carthamus tinctorius, IL-6, TNF-αAbstract
Inflammation is the body's physiological response to stimuli such as infection, trauma and chronic disease. Its exacerbation can lead to deterioration in health and damage to tissues in organs such as the lungs, kidneys and liver. The drive behind the development of anti-inflammatory drugs is to improve treatment efficacy and reduce adverse effects. The primary aim of this article is to deliberate on the pharmacological properties of compound from C.tinctorius as an anti-inflammatory agent. Through an extensive study of data we made a literature review of 17 research conducted to unravel the potential of compound from C.tinctorius as an anti-inflammatory agent. The ability of Carthamus tinctorius to alleviate inflammation is demonstrated by its ability to inhibit the activation of the NF-κB pathway and suppress the binding of the TGF-β1 promoter. These molecular processes hold the promise of ameliorating lung injury by attenuating the inflammatory response through suppression of the TLR 4-dependent signalling pathway, thereby improving the health of rats suffering from pulmonary fibrosis, a condition characterised by inflammation and vascular tissue repair. In addition, compounds in C. tinctorius are effective in reducing T lymphocyte (CD4) apoptosis in sepsis through their anti-inflammatory and anti-apoptotic effects. The anti-inflammatory mechanism is also demonstrated by reducing inflammatory cytokines such as IL-6 in the lungs, kidneys and liver.
Downloads
References
Bai, J., Zhao, J., Cui, D., Wang, F., Song, Y., Cheng, L., Gao, K., Wang, J., Li, L., Li, S., Jia, Y., & Wen, A. (2018). Protective effect of hydroxysafflor yellow A against acute kidney injury via the TLR4/NF-κB signaling pathway. Scientific Reports, 8(1), 1–11. https://doi.org/10.1038/s41598-018-27217-3 DOI: https://doi.org/10.1038/s41598-018-27217-3
Han, S.-Y., Li, H.-X., Ma, X., Zhang, K., Ma, Z.-Z., Jiang, Y., & Tu, P.-F. (2013). Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats. Journal of Ethnopharmacology, 145(3), 722–727. https://doi.org/10.1016/j.jep.2012.11.036 DOI: https://doi.org/10.1016/j.jep.2012.11.036
He, Y., Liu, Q., Li, Y., Yang, X., Wang, W., Li, T., Zhang, W., Cui, Y., Wang, C., & Lin, R. (2015). Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats. Journal of Physiology and Biochemistry, 71(1), 69–78. https://doi.org/10.1007/s13105-015-0382-3 DOI: https://doi.org/10.1007/s13105-015-0382-3
Hoffman, R. D., Li, C. Y., He, K., Wu, X., He, B. C., He, T. C., & Gao, J. L. (2020). Chinese Herbal Medicine and Its Regulatory Effects on Tumor Related T Cells. Frontiers in Pharmacology, 11(April), 1–14. https://doi.org/10.3389/fphar.2020.00492 DOI: https://doi.org/10.3389/fphar.2020.00492
Hu, N., Duan, J., Li, H., Wang, Y., Wang, F., Chu, J., Sun, J., Liu, M., Wang, C., Lu, C., & Wen, A. (2016). Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition. PloS One, 11(4), e0153409. https://doi.org/10.1371/journal.pone.0153409 DOI: https://doi.org/10.1371/journal.pone.0153409
Jiang, S., Shi, Z., Li, C., Ma, C., Bai, X., & Wang, C. (2014). Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation. International Journal of Clinical and Experimental Pathology, 7(5), 2595–2608.
Jin, M., Wang, L., Wu, Y., Zang, B. xia, & Tan, L. (2018). Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats. Chinese Journal of Integrative Medicine, 24(1), 32–39. https://doi.org/10.1007/s11655-017-2094-z DOI: https://doi.org/10.1007/s11655-017-2094-z
Jin, M., Wu, Y., Wang, L., Zang, B., & Tan, L. (2016). Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice. Phytotherapy Research, 30(4), 577–587. https://doi.org/10.1002/ptr.5560 DOI: https://doi.org/10.1002/ptr.5560
Kim, S.-Y., Hong, M., Deepa, P., Sowndhararajan, K., Park, S. J., Park, S., & Kim, S. (2023). Carthamus tinctorius Suppresses LPS-Induced Anti-Inflammatory Responses by Inhibiting the MAPKs/NF-κB Signaling Pathway in HaCaT Cells. Scientia Pharmaceutica, 91(1), 14. https://doi.org/10.3390/scipharm91010014 DOI: https://doi.org/10.3390/scipharm91010014
Kurniawan, Y. I., Louisa, M., Dewi, B. E., Hansur, L., Zaini, J., & Estuningtyas, A. (2023). The Effect of Carthamus tinctorius in Combination with Dexamethasone on Coagulation Markers in Mice Induced by SARS-CoV2 Spike Protein. Research Journal of Pharmacognosy, 10(4), 31–41. https://doi.org/10.22127/RJP.2023.400248.2129
Liu, Q., Wang, C. Y., Liu, Z., Ma, X. S., He, Y. H., Chen, S. S., & Bai, X. Y. (2014). Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling. Pharmaceutical Biology, 52(9), 1085–1093. https://doi.org/10.3109/13880209.2013.877491 DOI: https://doi.org/10.3109/13880209.2013.877491
Liu, S., Wang, Y., Wen, H., Sun, X., & Wang, Y. (2019). Hydroxysafflor Yellow A Inhibits TNF-α-Induced Inflammation of Human Fetal Lung Fibroblasts via NF-κB Signaling Pathway. Evidence-Based Complementary and Alternative Medicine : ECAM, 2019, 4050327. https://doi.org/10.1155/2019/4050327 DOI: https://doi.org/10.1155/2019/4050327
Liu, Y.-L., Liu, Y.-J., Liu, Y., Li, X.-S., Liu, S.-H., Pan, Y.-G., Zhang, J., Liu, Q., & Hao, Y.-Y. (2014). Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways. International Immunopharmacology, 23(2), 649–657. https://doi.org/10.1016/j.intimp.2014.10.018 DOI: https://doi.org/10.1016/j.intimp.2014.10.018
Lv, Y., Qian, Y., Fu, L., Chen, X., Zhong, H., & Wei, X. (2015). Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway. European Journal of Pharmacology, 769, 324–332. https://doi.org/10.1016/j.ejphar.2015.11.036 DOI: https://doi.org/10.1016/j.ejphar.2015.11.036
Lv, Y., Qian, Y., Ou-Yang, A., & Fu, L. (2016). Hydroxysafflor Yellow A Attenuates Neuron Damage by Suppressing the Lipopolysaccharide-Induced TLR4 Pathway in Activated Microglial Cells. Cellular and Molecular Neurobiology, 36(8), 1241–1256. https://doi.org/10.1007/s10571-015-0322-3 DOI: https://doi.org/10.1007/s10571-015-0322-3
Pan, R., Zhang, Y., Zang, B., Tan, L., & Jin, M. (2016). Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro. The Journal of Pharmacy and Pharmacology, 68(10), 1320–1330. https://doi.org/10.1111/jphp.12596 DOI: https://doi.org/10.1111/jphp.12596
Pan, R., Zhang, Y., Zheng, M., Zang, B., & Jin, M. (2017). Hydroxysafflor Yellow A Suppresses MRC-5 Cell Activation Induced by TGF-β1 by Blocking TGF-β1 Binding to TβRII. Frontiers in Pharmacology, 8, 264. https://doi.org/10.3389/fphar.2017.00264 DOI: https://doi.org/10.3389/fphar.2017.00264
Print, I., Online, I., Dehariya, R., & Dixit, A. K. (2015). A Review on Potential Pharmacological Uses of Carthamus tinctorius L . World Journal of Pharmaceutical Sciences, July 2015.
Song, L., Zhu, Y., Jin, M., & Zang, B. (2013). Hydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells. Fitoterapia, 84, 107–114. https://doi.org/10.1016/j.fitote.2012.11.004 DOI: https://doi.org/10.1016/j.fitote.2012.11.004
Sun, C.-Y., Pei, C.-Q., Zang, B.-X., Wang, L., & Jin, M. (2010). The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice. Phytotherapy Research : PTR, 24(12), 1788–1795. https://doi.org/10.1002/ptr.3166 DOI: https://doi.org/10.1002/ptr.3166
Tasneem, S., Liu, B., Li, B., Choudhary, M. I., & Wang, W. (2019). Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents. Pharmacological Research, 139(October 2018), 126–140. https://doi.org/10.1016/j.phrs.2018.11.001 DOI: https://doi.org/10.1016/j.phrs.2018.11.001
Wang, C., Huang, Q., Wang, C., Zhu, X., Duan, Y., Yuan, S., & Bai, X. (2013). Hydroxysafflor yellow A suppresses oleic acid-induced acute lung injury via protein kinase A. Toxicology and Applied Pharmacology, 272(3), 895–904. https://doi.org/10.1016/j.taap.2013.07.021 DOI: https://doi.org/10.1016/j.taap.2013.07.021
Wang, C., Wang, C., Ma, C., Huang, Q., Sun, H., Zhang, X., & Bai, X. (2014). Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 21(3), 199–206. https://doi.org/10.1016/j.phymed.2013.09.018 DOI: https://doi.org/10.1016/j.phymed.2013.09.018
Wang, C. Y., Liu, Q., Huang, Q. X., Liu, J. T., He, Y. H., Lu, J. J., & Bai, X. Y. (2013). Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 20(7), 592–599. https://doi.org/10.1016/j.phymed.2013.02.001 DOI: https://doi.org/10.1016/j.phymed.2013.02.001
Wang, J., Wang, P., Gui, S., Li, Y., Chen, R., Zeng, R., Zhao, P., Wu, H., Huang, Z., & Wu, J. (2017). Hydroxysafflor Yellow A Attenuates the Apoptosis of Peripheral Blood CD4(+) T Lymphocytes in a Murine Model of Sepsis. Frontiers in Pharmacology, 8, 613. https://doi.org/10.3389/fphar.2017.00613 DOI: https://doi.org/10.3389/fphar.2017.00613
Wang, J., Zhang, Q., Mei, X., & Zhang, X. (2014). Hydroxysafflor yellow A attenuates left ventricular remodeling after pressure overload-induced cardiac hypertrophy in rats. Pharmaceutical Biology, 52(1), 31–35. https://doi.org/10.3109/13880209.2013.805791 DOI: https://doi.org/10.3109/13880209.2013.805791
Wang, X., Jin, M., Tong, J., Wu, W., Li, J., & Zang, B. (2010). [Protective effect of hydroxysafflor yellow A against acute lung injury induced by oleic acid and lipopolysaccharide in rats]. Yao xue xue bao = Acta pharmaceutica Sinica, 45(7), 940–944.
Wang, Y., Xue, C., Dong, F., Peng, Y., Zhang, Y., Jin, M., Zang, B., & Tan, L. (2014). Hydroxysafflor yellow a attenuates small airway remodeling in a rat model of chronic obstructive pulmonary disease. Biological & Pharmaceutical Bulletin, 37(10), 1591–1598. https://doi.org/10.1248/bpb.b14-00198 DOI: https://doi.org/10.1248/bpb.b14-00198
Wu, W., Jin, M., Tong, J., Wang, X., & Zang, B. (2011). [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS]. Yao xue xue bao = Acta pharmaceutica Sinica, 46(2), 153–157.
Wu, Y., Wang, L., Jin, M., & Zang, B. X. (2012). Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury. Biological and Pharmaceutical Bulletin, 35(4), 515–522. https://doi.org/10.1248/bpb.35.515 DOI: https://doi.org/10.1248/bpb.35.515
Yang, F., Li, J., Zhu, J., Wang, D., Chen, S., & Bai, X. (2015). Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice. European Journal of Pharmacology, 754, 105–114. https://doi.org/10.1016/j.ejphar.2015.02.015 DOI: https://doi.org/10.1016/j.ejphar.2015.02.015
Yang, G., Zhou, X., Chen, T., Deng, Y., Yu, D., Pan, S., & Song, Y. (2015). Hydroxysafflor yellow A inhibits lipopolysaccharide-induced proliferation and migration of vascular smooth muscle cells via Toll-like receptor-4 pathway. International Journal of Clinical and Experimental Medicine, 8(4), 5295–5302.
Yao, Y., Yao, J., Du, Z., Wang, P., & Ding, K. (2018). Structural elucidation and immune-enhancing activity of an arabinogalactan from flowers of Carthamus tinctorius L. Carbohydrate Polymers, 202, 134–142. https://doi.org/10.1016/j.carbpol.2018.08.098 DOI: https://doi.org/10.1016/j.carbpol.2018.08.098
Ye, J., Lu, S., Wang, M., Ge, W., Liu, H., Qi, Y., Fu, J., Zhang, Q., Zhang, B., Sun, G., & Sun, X. (2020). Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy. Frontiers in Pharmacology, 11, 1170. https://doi.org/10.3389/fphar.2020.01170 DOI: https://doi.org/10.3389/fphar.2020.01170
Yeung, Y. T., Aziz, F., Guerrero-Castilla, A., & Arguelles, S. (2018). Signaling Pathways in Inflammation and Anti-inflammatory Therapies. Current Pharmaceutical Design, 24(14), 1449–1484. https://doi.org/10.2174/1381612824666180327165604 DOI: https://doi.org/10.2174/1381612824666180327165604
Yuan, W., Yang, D., Sun, X., Liu, W., Wang, L., Li, X., Man, X., & Fu, Q. (2014). Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II. International Journal of Clinical and Experimental Pathology, 7(9), 5772–5781.
Zhang, L., & Niu, Z. (2022). Hydroalcoholic Carthamus tinctorius L. Extract Attenuates TNBS-induced Ulcerative Colitis in Mice Via Downregulation of Inflammation and Oxidative Stress. Indian Journal of Pharmaceutical Education and Research, 56(3), 780–788. https://doi.org/10.5530/ijper.56.3.128 DOI: https://doi.org/10.5530/ijper.56.3.128
Zhang, Y., Guo, J., Dong, H., Zhao, X., Zhou, L., Li, X., Liu, J., & Niu, Y. (2011). Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis. European Journal of Pharmacology, 660(2–3), 438–444. https://doi.org/10.1016/j.ejphar.2011.04.015 DOI: https://doi.org/10.1016/j.ejphar.2011.04.015
Zhang, Y., Song, L., Pan, R., Gao, J., Zang, B.-X., & Jin, M. (2017). Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice. Biological & Pharmaceutical Bulletin, 40(2), 135–144. https://doi.org/10.1248/bpb.b16-00329 DOI: https://doi.org/10.1248/bpb.b16-00329
Zheng, M., Guo, X., Pan, R., Gao, J., Zang, B., & Jin, M. (2019). Hydroxysafflor Yellow A Alleviates Ovalbumin-Induced Asthma in a Guinea Pig Model by Attenuateing the Expression of Inflammatory Cytokines and Signal Transduction. Frontiers in Pharmacology, 10, 328. https://doi.org/10.3389/fphar.2019.00328 DOI: https://doi.org/10.3389/fphar.2019.00328
